E-LIB Suche - Ergebnisse für: Gilsenan, Alicia

1

Physician Awareness of the Safe Use of Cyproterone Acetate ..:

Sweeney, Carolyn ; Gilsenan, Alicia ; Calingaert, Brian...
Pharmaceutical Medicine. 38 (2024) 2 - p. 145-156 , 2024

Link: https://doi.org/10.1007/..

2

Post-Authorization Safety Studies of Acute Liver Injury and..:

Danysh, Heather E. ; Johannes, Catherine B. ; Beachler, Daniel C....
Drug Safety. 46 (2022) 2 - p. 175-193 , 2022

Link: https://doi.org/10.1007/..

3

Post-Authorization Safety Study of Hospitalization for Acut..:

Johannes, Catherine B. ; Beachler, Daniel C. ; Layton, J. Bradley...
Drug Safety. 46 (2022) 2 - p. 157-174 , 2022

Link: https://doi.org/10.1007/..

4

Incidence of adverse events with therapies targeting HER2-p..:

Perez, Edith A. ; Dang, Chau ; Lee, Caleb...
Breast Cancer Research and Treatment. 194 (2022) 1 - p. 1-11 , 2022

Link: https://doi.org/10.1007/..

5

Risk of Major Cardiovascular and Cerebrovascular Events in ..:

Forns, Joan ; Dudukina, Elena ; Hägg, David...
Neurology and Therapy. 11 (2022) 4 - p. 1659-1676 , 2022

Link: https://doi.org/10.1007/..

6

Real-world evidence:

Oppenheimer, John ; Slade, David J. ; Hahn, Beth A....
Annals of Allergy, Asthma & Immunology. 126 (2021) 4 - p. 385-393.e2 , 2021

Link: https://doi.org/10.1016/..

7

Identification and Validation of Major Cardiovascular Event..:

Ruigómez, Ana ; Plana, Estel ; Gilsenan, Alicia...
Drug Safety. 44 (2021) 5 - p. 541-551 , 2021

Link: https://doi.org/10.1007/..

8

Teriparatide Did Not Increase Adult Osteosarcoma Incidence ..:

Gilsenan, Alicia ; Midkiff, Kirk ; Harris, David...
Journal of Bone and Mineral Research. 36 (2020) 2 - p. 244-251 , 2020

Link: https://doi.org/10.1002/..

9

Assessing the incidence of osteosarcoma among teriparatide ..:

Gilsenan, Alicia ; Midkiff, Kirk ; Harris, David...
Pharmacoepidemiology and Drug Safety. 29 (2020) 12 - p. 1616-1626 , 2020

Link: https://doi.org/10.1002/..

10

Validation of cardiovascular outcomes and risk factors in t..:

Arana, Alejandro ; Margulis, Andrea V ; Varas‐Lorenzo, Cristina...
Pharmacoepidemiology and Drug Safety. 30 (2020) 2 - p. 237-247 , 2020

Link: https://doi.org/10.1002/..

11

Cardiovascular Safety of Prucalopride in Patients with Chro..:

Gilsenan, Alicia ; Fortuny, Joan ; Cainzos-Achirica, Miguel...
Drug Safety. 42 (2019) 10 - p. 1179-1190 , 2019

Link: https://doi.org/10.1007/..

12

Study Design and Cohort Comparability in a Study of Major C..:

Fortuny, Joan ; Gilsenan, Alicia ; Cainzos-Achirica, Miguel...
Drug Safety. 42 (2019) 10 - p. 1167-1177 , 2019

Link: https://doi.org/10.1007/..

13

386 - Non-Interventional Cohort Study of the Relative Incid..:

Gilsenan, Alicia ; Fortuny, Joan ; Plana, Estel...
Gastroenterology. 154 (2018) 6 - p. S-92-S-93 , 2018

Link: https://doi.org/10.1016/..

14

Challenges in studying very rare cancer outcomes and infreq..:

Andrews, Elizabeth B. ; Gilsenan, Alicia ; Midkiff, Kirk.
Annals of Epidemiology. 26 (2016) 11 - p. 751-753 , 2016

Link: https://doi.org/10.1016/..

15

The ATTEMPT cohort: a multi‐national longitudinal study of ..:

West, Robert ; Gilsenan, Alicia ; Coste, Florence...
Addiction. 101 (2006) 9 - p. 1352-1361 , 2006

Link: https://doi.org/10.1111/..